Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Pregnancy and Early Life Immunology

The Pregnancy and Early Life Immunology team's overall research vision is targeted towards understanding immunological development during early life.

Our focus is on how environmental exposures/inflammation can impact normal immune system development during early life to program an individual to be protected against or at increased risk for development of a broad range of diseases, including asthma and allergies, respiratory, metabolic and mental health.

The overall objective is the development of novel therapeutic strategies to prevent environmentally induced aberrant immune function and to improve long term health prospects for children.

Our future research goals include discovering:

  • How environmental exposures impact the immune system over the course of life from the prenatal period to adult, and contribute to disease pathogenesis and risk.
  • How the immune system can be trained to prevent or minimize increased risk for diseases due to environmental exposures/inflammation.
  • If the immune system can be reprogrammed, following such changes, to reduce/reverse disease susceptibility.
  • What drives sex specific differences in disease.
  • Understanding the role of precursor stem cell populations in peripheral tissues.

The primary focus of these current research programs is on allergic outcomes, infectious diseases, pregnancy health, mental health and whether responses are gender dependent.

Team leader

Head, Pregnancy and Early Life Immunology

Team members (7)

Head, Translational Immunology

Honorary Research Associate

Anya Jones
Anya Jones

BSc MSc PhD

Honorary Research Associate

Naomi Scott

Naomi Scott

Senior Research Officer

Michael Serralha

Michael Serralha

Research Assistant

Kyle Mincham

Kyle Mincham

Research Officer

Laith Harb

Laith Harb

PhD student

Pregnancy and Early Life Immunology projects

Show more projects

Reports and Findings

Reports and Findings

Sex assigned at birth may modify health-related quality of life in children treated with peanut oral immunotherapy

The high burden of peanut allergy underscores the need for treatment options that improve patient health-related quality of life (HRQL). However, the modifying effect of sex assigned at birth on treatment-related outcomes remains poorly understood. We sought to investigate whether sex modifies treatment effect on the change in overall and subdomain HRQL during the PPOIT-003 trial.

Reduced Type-I Interferon by Plasmacytoid Dendritic Cells and Asthma in School-Aged Children

Allergic sensitization and reduced ability to respond to viral infections may contribute to virus-induced wheeze and asthma development in young children. Plasmacytoid dendritic cells (pDC) are rare immune cells that produce type I interferons (IFN-I) and play a key role in orchestrating immune responses against viruses. 

Pragmatic Low-Dose Oral Immunotherapy for Preschool Children With Peanut Allergy: A Randomised Controlled Trial

Peanut allergy is the most common childhood-onset, persistent food allergy. Peanut oral immunotherapy (OIT) is a potential treatment, but few studies prospectively examine the outcome of peanut OIT in young children using parent-measured doses compared to standard care (peanut avoidance).

Plasma testosterone concentration is correlated with circulating immune cell abundance in transgender young people on gender-affirming hormone treatment

Sex hormones, such as oestrogen and testosterone, display significant immune modulatory properties. This is highly relevant for transgender (trans) people who undergo gender-affirming hormone (GAH) treatment. However, only a limited number of studies have evaluated the immunological impact of GAH treatments, and almost none have assessed the impact in trans young people.

Show all